Meningitis: Drug companies' lobbyist efforts grow for stricter regulation of compounder pharmacies; "costing them millions of dollars in annual profits"

http://www.voxxi.com/lobby-stricter-compounder-regulation/

Lobbyist efforts grow for stricter regulation of compounder pharmacies

Drug companies have ramped up lobbying efforts in Congress to force specialty pharmacies to either stop mass-producing drugs or face stricter regulation.

Commercial drug makers are also trying to prevent these specialty pharmacies, known as compounders, from making “knockoff” drugs for people and their pets that the companies say are costing them millions of dollars in annual profits, records and interviews show.

Read more: http://www.voxxi.com/lobby-stricter-compounder-regulation/#ixzz2MTlpu3Fp - See more at: http://www.voxxi.com/lobby-stricter-compounder-regulation/#sthash.xWZZe8rj.dpuf